As mentioned above, melatonin has the potential to attenuate AD pathology via numerous mechanisms including PI3K/Akt/GSK3β [37] and Notch1 signaling [120], and RAGE/NF-κB/JNK signaling pathway [117]. The gene discussed is GSK3B; the disease is Alzheimer disease.